Anita Giobbie-Hurder

Anita Giobbie-Hurder

UNVERIFIED PROFILE

Are you Anita Giobbie-Hurder?   Register this Author

Register author
Anita Giobbie-Hurder

Anita Giobbie-Hurder

Publications by authors named "Anita Giobbie-Hurder"

Are you Anita Giobbie-Hurder?   Register this Author

100Publications

4407Reads

16Profile Views

Immunity to X-linked inhibitor of apoptosis protein (XIAP) in malignant melanoma and check-point blockade.

Cancer Immunol Immunother 2019 Aug 18;68(8):1331-1340. Epub 2019 Jul 18.

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-019-02370-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6684401PMC
August 2019

Efficacy of PD-1 & PD-L1 inhibitors in older adults: a meta-analysis.

J Immunother Cancer 2018 04 4;6(1):26. Epub 2018 Apr 4.

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-018-0336-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5885356PMC
April 2018

Anti-CTLA-4 based therapy elicits humoral immunity to galectin-3 in patients with metastatic melanoma.

Oncoimmunology 2018 13;7(7):e1440930. Epub 2018 Mar 13.

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2018.1440930DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993498PMC
March 2018

A high level of estrogen-stimulated proteins selects breast cancer patients treated with adjuvant endocrine therapy with good prognosis.

Acta Oncol 2017 Sep 10;56(9):1161-1167. Epub 2017 May 10.

a Breast Cancer Group, Cell Death and Metabolism, Danish Cancer Society Research Center , Copenhagen , Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/0284186X.2017.1324211DOI Listing
September 2017

Risk of Bias and Heterogeneity-Reply.

JAMA Oncol 2017 06;3(6):858-859

Departments of Medical Oncology and Medicine, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2017.0160DOI Listing
June 2017

A Retrospective Analysis of the Efficacy of Pembrolizumab in Melanoma Patients With Brain Metastasis.

J Immunother 2017 04;40(3):108-113

*Massachusetts General Hospital Cancer Center †Department of Radiology, Massachusetts General Hospital, Harvard Medical School ‡Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CJI.0000000000000159DOI Listing
April 2017

Cholesterol, Cholesterol-Lowering Medication Use, and Breast Cancer Outcome in the BIG 1-98 Study.

J Clin Oncol 2017 Apr 13;35(11):1179-1188. Epub 2017 Feb 13.

Signe Borgquist and Judy E. Garber, Dana-Farber Cancer Institute, Harvard Medical School; Anita Giobbie-Hurder, International Breast Cancer Study Group (IBCSG) Statistical Center, Dana-Farber Cancer Institute; Richard D. Gelber, IBCSG Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, T.H. Chan Harvard School of Public Health, and Frontier Science and Technology Research Foundation; Karen N. Price, IBCSG Statistical Center and Frontier Science and Technology Research Foundation; Meredith M. Regan, IBCSG Statistical Center, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA; Signe Borgquist, Lund University, Lund, Sweden; Thomas P. Ahern, University of Vermont, Burlington, VT; Marco Colleoni and Aron Goldhirsch, IBCSG and European Institute of Oncology, Milan, Italy; István Láng, IBCSG and National Institute of Oncology, Budapest, Hungary; Marc Debled, Institut Bergonié, Bordeaux, France; Bent Ejlertsen, Danish Breast Cancer Cooperative Group, Rigshospitalet, Copenhagen, Denmark; Roger von Moos, Cantonal Hospital Graubuenden, Chur; Swiss Group for Clinical Cancer Research and IBCSG; Manuela Rabaglio, IBCSG Coordinating Center and Inselspital, Bern; Beat Thürlimann, Breast Center St. Gallen, Kantonsspital, St. Gallen; Swiss Group for Clinical Cancer Research and IBCSG, Bern, Switzerland; Ian Smith, The Royal Marsden Hospital, London, United Kingdom; and Alan S. Coates, IBCSG and University of Sydney School of Public Health, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.3116DOI Listing
April 2017

Incidence of Programmed Cell Death 1 Inhibitor-Related Pneumonitis in Patients With Advanced Cancer: A Systematic Review and Meta-analysis.

JAMA Oncol 2016 Dec;2(12):1607-1616

Department of Medical Oncology and Department of Medicine, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://oncology.jamanetwork.com/article.aspx?doi=10.1001/jam
Publisher Site
http://dx.doi.org/10.1001/jamaoncol.2016.2453DOI Listing
December 2016

A phase I trial of panobinostat (LBH589) in patients with metastatic melanoma.

Cancer Med 2016 11 17;5(11):3041-3050. Epub 2016 Oct 17.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.862DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5119958PMC
November 2016

VEGF Neutralization Plus CTLA-4 Blockade Alters Soluble and Cellular Factors Associated with Enhancing Lymphocyte Infiltration and Humoral Recognition in Melanoma.

Cancer Immunol Res 2016 10 22;4(10):858-868. Epub 2016 Aug 22.

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. Melanoma Disease Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5050160PMC
http://dx.doi.org/10.1158/2326-6066.CIR-16-0084DOI Listing
October 2016

Treatment Adherence and Its Impact on Disease-Free Survival in the Breast International Group 1-98 Trial of Tamoxifen and Letrozole, Alone and in Sequence.

J Clin Oncol 2016 07 23;34(21):2452-9. Epub 2016 May 23.

Jacquie H. Chirgwin and John F. Forbes, University of Newcastle; John F. Forbes, Calvary Mater Newcastle, Newcastle; Alan S. Coates, University of Sydney School of Public Health, Sydney, New South Wales; Jacquie H. Chirgwin, Box Hill Hospital; Jacquie H. Chirgwin, Maroondah Hospital; Jacquie H. Chirgwin, Monash University, Melbourne, Victoria, Australia; Anita Giobbie-Hurder, Karen N. Price, and Richard D. Gelber, International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute; Karen N. Price and Richard D. Gelber, Frontier Science and Technology Research Foundation; Richard D. Gelber, Harvard Medical School, Boston, MA; Bent Ejlertsen, Rigshospitalet, Copenhagen, Denmark; Marc Debled, Institut Bergonié, Bordeaux, France; Aron Goldhirsch and Marco Colleoni, European Institute of Oncology, Milan, Italy; Ian Smith, The Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom; Manuela Rabaglio, Inselspital, Bern; Beat Thürlimann, Kantonsspital, St. Gallen, Switzerland; Patrick Neven, University of Leuven; Patrick Neven, University Hospitals Leuven, Leuven, Belgium; István Láng, National Institute of Oncology, Budapest, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.8619DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962733PMC
July 2016

BRCA1/FANCD2/BRG1-Driven DNA Repair Stabilizes the Differentiation State of Human Mammary Epithelial Cells.

Mol Cell 2016 07 30;63(2):277-292. Epub 2016 Jun 30.

Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Genetics, Harvard Medical School, Boston, MA 02115, USA. Electronic address:

View Article

Download full-text PDF

Source
http://www.cell.com/molecular-cell/pdf/S1097-2765(16)30224-6
Web Search
http://dx.doi.org/10.1016/j.molcel.2016.05.038DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982517PMC
July 2016

Randomized trial of a physical activity intervention in women with metastatic breast cancer.

Cancer 2016 Apr 12;122(8):1169-77. Epub 2016 Feb 12.

Breast Oncology Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29899DOI Listing
April 2016

The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer Recurrence.

JAMA Oncol 2016 Feb;2(2):217-24

Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium2Medical Oncology Clinic, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2015.4377DOI Listing
February 2016

Phase 2 study of sunitinib in patients with metastatic mucosal or acral melanoma.

Cancer 2015 Nov 11;121(22):4007-15. Epub 2015 Aug 11.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29622DOI Listing
November 2015

Single Institution Experience of Ipilimumab 3 mg/kg with Sargramostim (GM-CSF) in Metastatic Melanoma.

Cancer Immunol Res 2015 Sep 5;3(9):986-91. Epub 2015 May 5.

Melanoma Disease Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-15-0066DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4561189PMC
September 2015

Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial.

J Clin Oncol 2015 Sep 27;33(25):2772-9. Epub 2015 Jul 27.

Otto Metzger Filho, Anita Giobbie-Hurder, and Eric P. Winer, Dana-Farber Cancer Institute; Richard D. Gelber and Meredith M. Regan, Harvard Medical School; Karen N. Price, Frontier Science and Technology Research, Boston, MA; Elizabeth Mallon, Southern General Hospital; Barry Gusterson, Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom; Giuseppe Viale, European Institute of Oncology and University of Milan; Marco Colleoni and Aron Goldhirsch, European Institute of Oncology, Milan, Italy; Beat Thürlimann, Kantonsspital, St. Gallen, and Swiss Group for Clinical Cancer Research, Bern, Switzerland; Bent Ejlertsen, Rigshospitalet, Copenhagen, Denmark; Marc Debled, Institut Bergoniié, Bordeaux, France; and Alan S. Coates, International Breast Cancer Study Group, Bern, Switzerland, and University of Sydney, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.60.8133DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4550691PMC
September 2015

Immunity to the vacuolar ATPase complex accessory unit ATP6S1 in patients with malignant melanoma.

Cancer Immunol Res 2015 Jan 11;3(1):59-67. Epub 2014 Nov 11.

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. Melanoma Disease Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. Center for Immuno-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-14-0184DOI Listing
January 2015

Response assessment in metastatic melanoma treated with ipilimumab and bevacizumab: CT tumor size and density as markers for response and outcome.

J Immunother Cancer 2014 18;2(1):40. Epub 2014 Nov 18.

Department of Medical Oncology and Department of Medicine, Dana-Farber Cancer Institute and Brigham and Women's Hospital, 450 Brookline Avenue, Boston, MA 02215 USA.

View Article

Download full-text PDF

Source
http://www.immunotherapyofcancer.org/content/2/1/40
Publisher Site
http://dx.doi.org/10.1186/s40425-014-0040-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236430PMC
November 2014

A randomized, placebo-controlled trial of melatonin on breast cancer survivors: impact on sleep, mood, and hot flashes.

Breast Cancer Res Treat 2014 Jun 10;145(2):381-8. Epub 2014 Apr 10.

Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-014-2944-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060962PMC
June 2014

Long-term risk perceptions of women with ductal carcinoma in situ.

Oncologist 2013 8;18(4):362-8. Epub 2013 Apr 8.

Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2012-0376DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3639521PMC
December 2013

Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin.

J Clin Oncol 2013 Sep 17;31(26):3182-90. Epub 2013 Jun 17.

F. Stephen Hodi, Anita Giobbie-Hurder, Philip Friedlander, Jason J. Luke, Katherine A. Zukotynski, Jeffrey T. Yap, Annick D. Van den Abbeele, and George D. Demetri, Dana-Farber Cancer Institute; Jonathan A. Fletcher, Meijun Zhu, and Adrian Marino-Enriquez, Brigham and Women's Hospital; Donald Lawrence, Keith T. Flaherty, and David E. Fisher, Massachusetts General Hospital, Boston, MA; Christopher L. Corless, Michael C. Heinrich, and Carol Beadling, Portland Veterans Administration Medical Center and Oregon Health & Science University, Portland, OR; Philip Friedlander, Mount Sinai Medical Center, New York, NY; Rene Gonzalez, University of Colorado Cancer Center, Aurora, CO; Jeffrey S. Weber, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Thomas F. Gajewski, University of Chicago, Chicago, IL; Steven J. O'Day, Beverly Hills Cancer Center, Beverly Hills, CA; Kevin B. Kim, The University of Texas MD Anderson Cancer Center, Houston, TX; Frances A. Collichio, The University of North Carolina at Chapel Hill, Chapel Hill, NC; and Marc S. Ernstoff, Geisel School of Medicine and Norris Cotton Cancer Center, Hanover, NH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.47.7836DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878082PMC
September 2013

Challenges of guarantee-time bias.

J Clin Oncol 2013 Aug 8;31(23):2963-9. Epub 2013 Jul 8.

Dana-Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.49.5283DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3732313PMC
August 2013

Developing a common language for tumor response to immunotherapy: immune-related response criteria using unidimensional measurements.

Clin Cancer Res 2013 Jul 6;19(14):3936-43. Epub 2013 Jun 6.

Department of Radiology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, 450 Brookline Ave., Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-13-0895DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3740724PMC
July 2013

Neurologic features of Hutchinson-Gilford progeria syndrome after lonafarnib treatment.

Neurology 2013 Jul 28;81(5):427-30. Epub 2013 Jun 28.

Department of Neurology, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0b013e31829d85c0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776537PMC
July 2013

Quality of life and symptoms in male breast cancer survivors.

Breast 2013 Apr 11;22(2):197-199. Epub 2013 Jan 11.

Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2012.12.014DOI Listing
April 2013

Psychosexual functioning and body image following a diagnosis of ductal carcinoma in situ.

J Sex Med 2013 Feb 19;10(2):370-7. Epub 2012 Jul 19.

Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1743-6109.2012.02852.xDOI Listing
February 2013

The activation of MAPK in melanoma cells resistant to BRAF inhibition promotes PD-L1 expression that is reversible by MEK and PI3K inhibition.

Clin Cancer Res 2013 Feb 24;19(3):598-609. Epub 2012 Oct 24.

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-12-2731DOI Listing
February 2013

Immunity to the melanoma inhibitor of apoptosis protein (ML-IAP; livin) in patients with malignant melanoma.

Cancer Immunol Immunother 2012 May 28;61(5):655-65. Epub 2011 Oct 28.

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-011-1124-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3337996PMC
May 2012

The protein kinase C inhibitor enzastaurin exhibits antitumor activity against uveal melanoma.

PLoS One 2012 12;7(1):e29622. Epub 2012 Jan 12.

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0029622PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3257235PMC
May 2012

Quality of life in long-term survivors of metastatic breast cancer.

Clin Breast Cancer 2012 Apr;12(2):119-26

Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2012.01.010DOI Listing
April 2012

Hutchinson-Gilford progeria is a skeletal dysplasia.

J Bone Miner Res 2011 Jul;26(7):1670-9

Division of Adolescent Medicine and Endocrinology, Children's Hospital Boston, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jbmr.392DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650062PMC
July 2011

Interpreting Breast International Group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer.

Breast Cancer Res 2011 May 26;13(3):209. Epub 2011 May 26.

International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr2837DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218925PMC
May 2011

Impact of a mixed strength and endurance exercise intervention on levels of adiponectin, high molecular weight adiponectin and leptin in breast cancer survivors.

Cancer Causes Control 2009 Oct 13;20(8):1523-8. Epub 2009 May 13.

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10552-009-9358-3DOI Listing
October 2009

Physical activity behaviors in women with newly diagnosed ductal carcinoma-in-situ.

Ann Surg Oncol 2009 Jan 24;16(1):106-12. Epub 2008 Oct 24.

Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-008-0174-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5842912PMC
January 2009

Does delaying repair of an asymptomatic hernia have a penalty?

Am J Surg 2008 Jan;195(1):89-93

University of Nebraska, Nebraska Medical Center, Omaha, NE, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjsurg.2007.07.021DOI Listing
January 2008

Factors associated with postoperative complications and hernia recurrence for patients undergoing inguinal hernia repair: a report from the VA Cooperative Hernia Study Group.

Am J Surg 2007 Nov;194(5):611-7

George E. Wahlen Salt Lake City VA Health Care System and University of Utah Department of Surgery, VAMC-112, 500 Foothill Dr, Salt Lake City, UT 84148, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjsurg.2007.07.018DOI Listing
November 2007

Disease progression in Hutchinson-Gilford progeria syndrome: impact on growth and development.

Pediatrics 2007 Oct;120(4):824-33

Department of Pediatrics, Rhode Island Hospital, Providence, Rhode Island, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1542/peds.2007-1357DOI Listing
October 2007

Does delay of hernia repair in minimally symptomatic men burden the patient's family?

J Am Coll Surg 2007 Sep 19;205(3):409-12. Epub 2007 Jul 19.

Institute of Healthcare Studies, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jamcollsurg.2007.04.020DOI Listing
September 2007

Fourteen-year follow-up of a patient-fitted total temporomandibular joint reconstruction system.

J Oral Maxillofac Surg 2007 Jun;65(6):1140-8

Department of Surgery, Division of Oral and Maxillofacial Surgery and Dental Medicine, Stritch School of Medicine, Loyola University Medical Center, Maywood, IL 60153, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S027823910601883
Publisher Site
http://dx.doi.org/10.1016/j.joms.2006.10.006DOI Listing
June 2007

Cost effectiveness of laparoscopic versus open mesh hernia operation: results of a Department of Veterans Affairs randomized clinical trial.

J Am Coll Surg 2006 Oct 13;203(4):447-57. Epub 2006 Jul 13.

Cooperative Studies Program Coordinating Center, Midwest Center for Health Services and Policy Research, Edward Hines Jr. VA Hospital, PO Box 5000 (151-V), 5th Avenue and Roosevelt Road, Hines, IL 60141, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jamcollsurg.2006.05.019DOI Listing
October 2006

Tension-free repair versus watchful waiting for men with asymptomatic or minimally symptomatic inguinal hernias: a cost-effectiveness analysis.

J Am Coll Surg 2006 Oct 24;203(4):458-68. Epub 2006 Aug 24.

Cooperative Studies Program Coordinating Center, Edward Hines Jr VA Hospital, 5th Avenue and Roosevelt Road, Hines, IL 60141, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jamcollsurg.2006.06.010DOI Listing
October 2006

Patient-reported outcomes after inguinal herniorrhaphy.

Surgery 2006 Aug;140(2):198-205

Deep South Center for Effectiveness Research, Birmingham VA Medical Center and Department of Surgery, University of Alabama, Birmingham, AL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.surg.2006.02.003DOI Listing
August 2006

Establishing a prognosis for functional outcome during coma recovery.

Brain Inj 2006 Jun;20(7):743-58

The Department of Veterans Affairs (VA), Research Service, Edward Hines Jr. VA Hospital, Hines, IL 60141, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/02699050600676933DOI Listing
June 2006

Proficiency of surgeons in inguinal hernia repair: effect of experience and age.

Ann Surg 2005 Sep;242(3):344-8; discussion 348-52

VA Salt Lake City Health Care System, University of Utah Health Sciences Center, Salt Lake City, UT 84148, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1357742PMC
http://dx.doi.org/10.1097/01.sla.0000179644.02187.eaDOI Listing
September 2005